Trump Administration Ends Federal Funding for Fentanyl Test Strips, Raising Overdose Risks

Federal Funding for Fentanyl Test Strips Eliminated

The Trump administration has canceled federal funding for fentanyl test strips, which detect dangerous substances like fentanyl, xylazine, and medetomidine in illicit drugs. The decision, reported by CBS News and confirmed by a letter from the Substance Abuse and Mental Health Services Administration (SAMHSA), bars government funds from being used to purchase the strips, increasing the risk of fatal overdoses.

Test Strips: A Life-Saving Tool at $1 Each

Public health organizations are alarmed by the move, as fentanyl test strips cost only about $1 each and can detect deadly substances in powder or pill form. The strips are widely used to prevent overdoses by allowing users to check drugs before consumption.

"People are just astonished," said Maritza Perez Medina, director of federal policy at the Drug Policy Alliance. "There has been a lot of confusion about where this came from." Medina called the strips a "critical, life-saving tool."

Executive Order Cited as Justification

The letter from SAMHSA cites a July 2025 executive order from President Trump that prohibits the agency from using its funding for programs that "only facilitate illegal drug use." An HHS spokesperson told CBS that the letter clarifies SAMHSA funding restrictions, excluding "practices that facilitate illicit drug use and are incompatible with federal laws."

Legal and Public Health Context

In 45 states and Washington, D.C., fentanyl test strips are not classified as drug paraphernalia. Additionally, Nevada and California provide online resources for locating the strips. Congress protected their use in 2018, and as of July 2025, SAMHSA still allowed its funding to pay for them.

However, the new policy reverses this stance, leaving organizations nationwide without critical funding to prevent overdoses. Shreeta Waldon, executive director of the Kentucky Harm Reduction Coalition, told CBS that her organization was informed it would lose a $400,000 grant and has only a month’s supply of test strips remaining after distributing 48,465 strips in the first quarter of 2026.

"It doesn’t make sense that one day something is an evidence-based protocol, and you decide, because of political climate, it is no longer evidence-based," Waldon said. "If they follow the science and the data, we would never move in this direction."

Broader Public Health Concerns

The Trump administration’s policy shift aligns with other public health decisions, such as discouraging vaccines and cutting cancer research, which critics argue are not based on preventing deaths. Drug overdoses remain a widespread issue, including in rural areas where support for the president is strongest. The loss of test strips will remove a vital tool for harm reduction in these communities.